Growth Metrics

Artivion (AORT) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Artivion 1.02 Bn 961.00 Mn 75.45 Mn -188.70%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -188.70%
Dec 31, 2025 -167.02%
Sep 30, 2025 56.68%
Jun 30, 2025 -30.80%
Mar 31, 2025 -0.75%
Dec 31, 2024 -328.06%
Sep 30, 2024 -414.46%
Jun 30, 2024 -135.50%
Mar 31, 2024 -27.01%
Dec 31, 2023 -0.04%
Sep 30, 2023 32.26%
Jun 30, 2023 409.62%
Mar 31, 2023 -4.99%
Dec 31, 2022 5.12%
Sep 30, 2022 -119.68%
Jun 30, 2022 63.33%
Mar 31, 2022 -234.32%
Dec 31, 2021 -19.86%
Sep 30, 2021 123.40%
Jun 30, 2021 -295.06%
Mar 31, 2021 72.10%
Dec 31, 2020 26.46%
Sep 30, 2020 -287.57%
Jun 30, 2020 28.89%
Mar 31, 2020 -103.43%
Dec 31, 2019 -85.68%
Sep 30, 2019 -1,152.34%
Jun 30, 2019 -46.76%
Mar 31, 2019 32.66%
Dec 31, 2018 98.97%
Sep 30, 2018 -18.58%
Jun 30, 2018 32.32%
Mar 31, 2018 -59.92%
Dec 31, 2017 -2,032.25%
Sep 30, 2017 40.77%
Jun 30, 2017 -11.37%
Mar 31, 2017 98.03%
Dec 31, 2016 -363.52%
Sep 30, 2016 -91.63%
Jun 30, 2016 -742.86%
Mar 31, 2016 -4,232.58%
Dec 31, 2015 -208.24%
Sep 30, 2015 -0.20%
Jun 30, 2015 88.75%
Mar 31, 2015 7.68%
Dec 31, 2014 -103.82%
Sep 30, 2014 1.46%
Jun 30, 2014 -62.69%
Mar 31, 2014 -56.62%
Dec 31, 2013 847.49%
Sep 30, 2013 38.95%
Jun 30, 2013 92.99%
Mar 31, 2013 -35.87%
Dec 31, 2012 -225.94%
Sep 30, 2012 64.73%
Jun 30, 2012 15.97%
Mar 31, 2012 -167.46%
Dec 31, 2011 26.10%
Sep 30, 2011 23.22%